House of Commons Science and Technology Committee

House of Commons Science and Technology Committee
Name	House of Commons Science and Technology Committee
Legislature	Parliament of the United Kingdom
Chamber	House of Commons of the United Kingdom
Established	1987
Jurisdiction	United Kingdom
Parent committee	Select committee (House of Commons)

House of Commons Science and Technology Committee is a select committee of the House of Commons of the United Kingdom charged with examining science and technology policy across United Kingdom departments and public bodies. It conducts inquiries, publishes reports, summons witnesses from academia, industry and public institutions such as Imperial College London, University of Oxford and National Health Service (England), and influences legislative and administrative action. The committee interacts with stakeholders including Engineering and Physical Sciences Research Council, Medical Research Council, Royal Society, Nesta, and international counterparts such as the United States Congress committees and the European Parliament.

History

The committee was established following changes to select committee arrangements in 1987, arising from broader reforms associated with debates in the House of Commons of the United Kingdom and recommendations from figures linked to the 1980s United Kingdom political reform era. Early work intersected with inquiries by bodies such as the Royal Society and cross-party projects tied to figures from Conservative Party (UK), Labour Party (UK), and Liberal Democrats (UK). Over successive parliaments the committee’s remit evolved alongside policy developments driven by events such as the rise of the Human Genome Project, the expansion of the European Research Area, controversies like the BSE outbreak in the United Kingdom, and strategic priorities reflected in White Papers produced by the Department for Business, Innovation and Skills and later Department for Business, Energy and Industrial Strategy. The committee’s work has been shaped by chairs from MPs aligned with major parliamentary groups and notable public figures from institutions like Wellcome Trust and UK Research and Innovation.

Remit and Powers

The committee exercises powers typical of a Select committee (House of Commons), including the ability to send for persons, papers and records, take oral and written evidence, and report to the House of Commons of the United Kingdom. Its scope covers interactions with departments and agencies such as Department for Business, Energy and Industrial Strategy, Department of Health and Social Care, UK Space Agency, Met Office, and funding councils like Research England. The committee assesses policy instruments, regulatory frameworks and public investments related to initiatives such as the Industrial Strategy (United Kingdom), Net Zero emissions targets, and research funding tied to frameworks like the Horizon 2020 programme. It also liaises with statutory regulators including Medicines and Healthcare products Regulatory Agency, Ofcom, and the Information Commissioner's Office when inquiries touch on safety, data and public interest.

Membership and Leadership

Membership reflects party balance within the House of Commons of the United Kingdom and is periodically renewed after general elections or reshuffles. Chairs historically have included MPs who engaged with science policy in committees of Commons Select Committee tradition and who collaborated with organizations such as Royal Academy of Engineering and Biotechnology and Biological Sciences Research Council. Members summon expertise from peers at University of Cambridge, University College London, Edinburgh University, and industry leaders from firms like Rolls-Royce Holdings, GlaxoSmithKline, AstraZeneca, and Rolls-Royce. The committee’s secretariat liaises with parliamentary authorities including the Clerk of the House of Commons and the House of Commons Commission.

Investigations and Reports

The committee conducts thematic inquiries and rapid reviews on topics ranging from the governance of emerging technologies to sector crises. Major inquiries have addressed issues linked to the Human Fertilisation and Embryology Act 1990, the response to pandemics such as the COVID-19 pandemic, the regulation of gene editing technologies like CRISPR-Cas9, and the resilience of supply chains highlighted by events affecting companies such as Port of Dover logistics and sectors represented by Society of Chemical Industry. Reports frequently cite expert witnesses from institutions including Wellcome Trust, Wellcome Sanger Institute, Francis Crick Institute, Royal College of Physicians, National Institute for Health and Care Excellence, and international agencies like the World Health Organization. Recommendations have targeted ministers across portfolios including Prime Minister of the United Kingdom and secretaries of state from Department for Business, Energy and Industrial Strategy and Department of Health and Social Care.

Impact and Influence

The committee has effected change by prompting government responses, influencing legislation debated in the House of Commons of the United Kingdom, and shaping regulatory practice at bodies such as the Medicines and Healthcare products Regulatory Agency and UK Research and Innovation. Its reports have informed policy shifts during crises involving public health institutions like the National Health Service (England) and research funding priorities at councils including the Economic and Social Research Council. The committee’s high-profile inquiries into pandemic preparedness and scientific advice raised scrutiny of advisory bodies such as the Scientific Advisory Group for Emergencies and stimulated cross-jurisdictional dialogue with counterparts including committees in the United States Congress and Parliament of Canada.

Criticism and Controversies

Critics have argued the committee’s influence varies with political context, noting tensions during inquiries that intersect with partisan disputes involving the Conservative Party (UK) and Labour Party (UK). Controversies have arisen over access to classified or commercially sensitive documents from contractors like Serco Group and debates about the limits of parliamentary privilege when examining entities such as the National Cyber Security Centre and private firms like Babcock International. Some stakeholders from universities including University of Oxford and think tanks like Institute for Government have critiqued methodology, urging stronger engagement with peers from Royal Society and Academy of Medical Sciences to bolster technical rigour. PMID-style disputes and public disagreements with government departments have occasionally led to high-profile media coverage involving broadcasters like BBC and Financial Times.

Category:Committees of the House of Commons of the United Kingdom